264 related articles for article (PubMed ID: 9824483)
1. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
[TBL] [Abstract][Full Text] [Related]
2. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
Krenger W; Rossi S; Piali L; Holländer GA
Blood; 2000 Jul; 96(1):347-54. PubMed ID: 10891472
[TBL] [Abstract][Full Text] [Related]
3. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.
Baker J; Verneris MR; Ito M; Shizuru JA; Negrin RS
Blood; 2001 May; 97(10):2923-31. PubMed ID: 11342413
[TBL] [Abstract][Full Text] [Related]
4. Functional changes of intestinal intraepithelial lymphocytes during acute graft versus host disease: correlation with phenotype.
Nussler NC; Hoffman RA; McCarthy SA; Simmons RL
Int Immunol; 1996 Nov; 8(11):1767-77. PubMed ID: 8943572
[TBL] [Abstract][Full Text] [Related]
5. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.
Kataoka Y; Iwasaki T; Kuroiwa T; Seto Y; Iwata N; Hashimoto N; Ogata A; Hamano T; Kakishita E
Immunology; 2001 Jul; 103(3):310-8. PubMed ID: 11454060
[TBL] [Abstract][Full Text] [Related]
6. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
7. IL-18 prevents the development of chronic graft-versus-host disease in mice.
Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids.
Krenger W; Rossi S; Holländer GA
Transplantation; 2000 May; 69(10):2190-3. PubMed ID: 10852622
[TBL] [Abstract][Full Text] [Related]
9. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
Zhang Y; Hexner E; Frank D; Emerson SG
J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
13. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
15. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
16. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
Thiele DL; Charley MR; Calomeni JA; Lipsky PE
J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
[TBL] [Abstract][Full Text] [Related]
17. Thymic hormone modulation of age-induced changes in the induction of graft-versus-host disease by DBA/2J lymphocytes.
Fast LD; Kouttab NM; Badamchian M; Goldstein AL
Cell Immunol; 1990 Nov; 131(1):232-41. PubMed ID: 2225080
[TBL] [Abstract][Full Text] [Related]
18. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
[TBL] [Abstract][Full Text] [Related]
19. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
Via CS; Rus V; Gately MK; Finkelman FD
J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
[TBL] [Abstract][Full Text] [Related]
20. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
Koyasu S
J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]